IVDD vs IVDR: Greatest Impacts on IVD Manufacturers
The IVDR has brought about a paradigm shift in the regulatory framework for IVDs placed on the…
Resources & News
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 613–621 of 669
EU Device Regulatory Compliance: A Comprehensive Guide
While the focus of EU regulatory compliance for medical devices and…
EU Importation and Taxation Considerations: DDP vs DAP
Asides from the regulatory hurdles necessary to navigate when marketing your devices in the EU, taxation requirements are also…
MDR Clinical Evaluation Reports for Lower-Risk Class Devices
It is known that the main objective of the implementation of the MDR was to strengthen the regulatory framework…
Key Takeaways from RAPS Euro Convergence: Advancing Regulatory Practices
The RAPS Euro Convergence Conference proved to be an exceptional gathering of regulatory professionals, offering an unparalleled level of…
New Swissmedic Class 1 MDR Device Labeling Requirements
The Swissmedic guidance mandates the inclusion of CH-REP (Swiss Responsible Person) information on the labels of Class…
PMPF Under the IVDR: Methods, Justifications, and Triggers
As we have mentioned in…
What is the Difference Between PMS and PMPF Under the IVDR?
While post-market clinical follow-up (PMCF) studies were a concept…
Linking IVDR Performance Evaluations and Risk Management
Similar to…
Showing 613–621 of 669